Stay updated on RPL554 MDI for COPD Treatment Clinical Trial
Sign up to get notified when there's something new on the RPL554 MDI for COPD Treatment Clinical Trial page.

Latest updates to the RPL554 MDI for COPD Treatment Clinical Trial page
- CheckyesterdayChange DetectedThe sponsor field now lists Verona Pharma, Inc., a subsidiary of Merck & Co., Inc., as the sponsor. Verona Pharma plc is no longer referenced in the sponsor information.SummaryDifference0.2%

- Check8 days agoChange DetectedThe page now shows a new revision tag (v3.5.3) replacing the previous (v3.5.2), signaling an administrative update. There are no changes to study content or results.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check30 days agoChange DetectedUpdated the collaborator entry to IQVIA Pty Ltd, replacing Iqvia Pty Ltd.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision notes updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No user-facing content was changed.SummaryDifference0.0%

Stay in the know with updates to RPL554 MDI for COPD Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RPL554 MDI for COPD Treatment Clinical Trial page.